SCHEMBL243699

SCHEMBL243699

CC1(C)CC(=O)C(C)(C)N1O

nearest known ligand 0.43

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.43
GAA P10253 2/20 0.43
L3MBTL1 Q9Y468 2/20 0.43
KDM4E B2RXH2 1/20 0.43
ALDH1A1 P00352 1/20 0.43
KMT2A Q03164 1/20 0.33
LMNA P02545 1/20 0.32
CYP2C9 P11712 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4957370 0.97 MAPT (0.46) MAPTGAAL3MBTL1KDM4EALDH1A1
Hydrochloric Acid SCHEMBL4445454 0.95 MAPT (0.41) MAPTGAAL3MBTL1KDM4EALDH1A1
SCHEMBL8463169 0.78 ALDH1A1 (0.33) MAPTGAAL3MBTL1KDM4EALDH1A1
SCHEMBL20650993 0.78 KDM4E (0.37) MAPTGAAL3MBTL1KDM4EALDH1A1
SCHEMBL23895142 0.77 KDM4E (0.33) MAPTGAAL3MBTL1KDM4EALDH1A1
SCHEMBL85990 0.76 GAA (0.38) MAPTGAAL3MBTL1KDM4EALDH1A1
SCHEMBL50752 0.74 ALDH1A1 (0.30) ALDH1A1
Hydrochloric Acid SCHEMBL7516042 0.74 GAA (0.37) MAPTGAAL3MBTL1KDM4EALDH1A1
Ethylene SCHEMBL3939551 0.72 GAA (0.36) MAPTGAAL3MBTL1KDM4EALDH1A1
SCHEMBL4438105 0.72 LMNA (0.32) MAPTGAAL3MBTL1KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 365 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2125716-A2 HYDROXYLAMINE COMPOUNDS AND METHODS OF THEIR USE Othera Holding, Inc. (US) 2009-12-02 EP claimed
US-20080280890-A1 HYDROXYLAMINE COMPOUNDS AND METHODS OF THEIR USE COLBY PHARMACEUTICAL COMPANY 2008-11-13 US claimed
WO-2008103613-A2 HYDROXYLAMINE COMPOUNDS AND METHODS OF THEIR USE OTHERA HOLDING, INC. (US) 2008-08-28 WO claimed
EP-3906245-B1 MULTIFUNCTIONAL ORGANOSILICON COMPOUND AND RELATED METHODS, COMPOUNDS, AND COMPOSITIONS DOW SILICONES CORP (US) 2024-05-29 EP disclosed
EP-4368653-A1 DI(METH)ACRYLATE, PHOTOCURABLE RESIN COMPOSITION, AND PHOTOCURABLE RESIN COMPOSITION FOR ADHESIVE NOF Corporation (JP) 2024-05-15 EP disclosed
WO-2024095995-A1 ESTER-COMPOUND-CONTAINING COMPOSITION AND METHOD FOR PRODUCING SAME, POLYMERIZABLE COMPOSITION, AND (METH)ACRYLIC POLYMER AND METHOD FOR PRODUCING SAME 三菱ケミカル株式会社 2024-05-10 WO disclosed
WO-2024095957-A1 ESTER COMPOUND-CONTAINING COMPOSITION, METHOD FOR PRODUCING SAME, POLYMERIZABLE COMPOSITION, (METH)ACRYLIC POLYMER, AND METHOD FOR PRODUCING SAME 三菱ケミカル株式会社 2024-05-10 WO disclosed
WO-2024090544-A1 METHACRYLATE-CONTAINING COMPOSITION, METHOD FOR PRODUCING METHACRYLIC ESTER, POLYMERIZABLE COMPOSITION, AND METHOD FOR PRODUCING METHACRYLIC ACID POLYMER 三菱ケミカル株式会社 2024-05-02 WO disclosed
WO-2024090576-A1 MONOMER COMPOSITION, METHACRYLIC RESIN COMPOSITION AND PRODUCTION METHOD THEREFOR, AND MOLDED RESIN OBJECT 三菱ケミカル株式会社 2024-05-02 WO disclosed
US-20240124685-A1 Methyl Methacrylate-Containing Composition, Storage Method for Methyl Methacrylate-Containing Composition, and Production Method for Methyl Methacrylate Polymer MITSUBISHI CHEMICAL CORPORATION (JP) 2024-04-18 US disclosed
WO-2024063093-A1 ESTER-COMPOUND-CONTAINING COMPOSITION AND METHOD FOR PRODUCING SAME, METHODS FOR PRODUCING POLYMERIZABLE COMPOSITION AND (METH)ACRYLIC POLYMER 三菱ケミカル株式会社 2024-03-28 WO disclosed
EP-0620206-B2 Method for inhibiting polymerization of (meth)acrylic acid and esters thereof NIPPON CATALYTIC CHEM IND (JP) 2000-05-17 EP disclosed
EP-0810196-B1 Method for inhibiting polymerization of (meth) acrylic acid or esters thereof MITSUBISHI CHEM CORP (JP) 2000-04-05 EP disclosed
US-5856562-A Method for inhibiting polymerization of (meth) acrylic acid or esters thereof MITSUBISHI CHEMICAL CORPORATION (JP) 1999-01-05 US disclosed
EP-0685447-B1 Method for inhibiting polymerization of (meth)acrylic acid and esters thereof NIPPON CATALYTIC CHEM IND (JP) 1998-10-14 EP disclosed
EP-0810196-A1 Method for inhibiting polymerization of (meth) acrylic acid or esters thereof MITSUBISHI CHEMICAL CORPORATION (JP) 1997-12-03 EP disclosed
US-5504243-A ADDING N-OXYL COMPOUND AND MANGANESE OR COPPER SALT NIPPON SHOKUBAI CO., LTD. (JP) 1996-04-02 US disclosed
EP-0685447-A2 Method for inhibiting polymerization of (meth)acrylic acid and esters thereof NIPPON SHOKUBAI CO., LTD. (JP) 1995-12-06 EP disclosed
EP-0620206-A1 Method for inhibiting polymerization of (meth)acrylic acid and esters thereof NIPPON SHOKUBAI CO., LTD. (JP) 1994-10-19 EP disclosed
US-5322960-A Using synergistic mixture of N-oxyl compound, phenol compound, phenothiazine NIPPON SHOKUBAI CO., LTD. (JP) 1994-06-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080280890-A1 HYDROXYLAMINE COMPOUNDS AND METHODS OF THEIR USE HDGF, HMOX1, HMOX2 MAPT 2334/4885GAA 3200/4885L3MBTL1 4642/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.